ALFA Finder
17:25 IST
NSE
Earnings Call
Accretion Pharmaceuticals Investor Presentation: Key Takeaways
H1 FY27 revenue ₹55.04 Cr (+25.83% YoY), PAT ₹8.20 Cr (+72.63%), EBITDA margin 22.48%. Export share rose to 18.15%.
Accretion Pharmaceuticals Ltd
- Share price
- ₹203.75
- Market cap
- ₹226.5 Cr
- Revenue (annual)
- ₹89.63 Cr
- Net profit (annual)
- ₹9.67 Cr
- P/E (TTM)
- 23.4×Sector 43.8×
- Promoter holding
- 73.52%+0.00% QoQ
- FII holding
- 0.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 7Annual General Meeting 4Financial Results 3Earnings Call 2Results Update 1Results Correction 1Management Change 1Board Meeting Outcome 1Board Meeting Date 1
Time
2 announcements with these filters
14:48 IST
NSE
Earnings Call
Accretion Pharmaceuticals Earnings Call: Key Takeaways
Accretion Pharmaceuticals reported strong FY26 performance with ₹89.63 cr total income and 10.8% PAT margin, driven by export growth.